Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Vladimir, Gilca"'
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Influenza is associated with a decline in functional abilities among Canadian older adults, although specific impacts on daily life have not been fully explored. Methods In August 2019 and May 2020, we conducted surveys of Canadia
Externí odkaz:
https://doaj.org/article/e89c7757415743c8b3b4a15844c672ba
Autor:
Chantal Sauvageau, Vladimir Gilca, Manale Ouakki, Marilou Kiely, François Coutlée, Sara Mathieu-Chartier, Fannie Defay, Gilles Lambert
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4393-4396 (2021)
Concerns were raised about HPV vaccination possibly leading to riskier sexual behavior. We assessed sexual behaviors, risk of sexually transmitted infection, and attendance to cervical cancer screening by HPV vaccinated and unvaccinated young women.
Externí odkaz:
https://doaj.org/article/4bbd680f9897484ca260746bdd337d32
Autor:
Sabryna Nantel, Benoîte Bourdin, Kelsey Adams, Julie Carbonneau, Henintsoa Rabezanahary, Marie-Ève Hamelin, Deirdre McCormack, Patrice Savard, Yves Longtin, Matthew P. Cheng, Gaston De Serres, Jacques Corbeil, Vladimir Gilca, Mariana Baz, Guy Boivin, Caroline Quach, Hélène Decaluwe
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Public health vaccination recommendations for COVID-19 primary series and boosters in previously infected individuals differ worldwide. As infection with SARS-CoV-2 is often asymptomatic, it remains to be determined if vaccine immunogenicity is compa
Externí odkaz:
https://doaj.org/article/1eddf383df40436d864db795d0db6a7d
Autor:
Chantal Sauvageau, Gitika Panicker, Elizabeth R. Unger, Gaston De Serres, John Schiller, Manale Ouakki, Vladimir Gilca
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 3, Pp 590-594 (2020)
The main objective of this post hoc analysis is to compare the magnitude of the immune response to HPV31/33/45/52 and 58 after a dose of 9vHPV vaccine given to naïve (previously unvaccinated) subjects and subjects previously vaccinated with a dose o
Externí odkaz:
https://doaj.org/article/5e24d32e5d2c41089221e9d63f62746d
Autor:
William A. Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield, Paul Roumeliotis, Emmanouil Rampakakis, Vivien Brown, John Yaremko, Paul Van Buynder, Constantina Boikos, James A. Mansi
Publikováno v:
Vaccines, Vol 11, Iss 1, p 17 (2022)
This study evaluated the impact of a continuing medical education (CME) program that emphasized actionable information, motivation to act, and skills to strengthen physician recommendations for seasonal influenza vaccination in children 6 through 23
Externí odkaz:
https://doaj.org/article/d4b40a900a024420b7db5e7017dae4bc
Autor:
William A. Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield, Paul Roumeliotis, Emmanouil Rampakakis, Vivien Brown, John Yaremko, Paul Van Buynder, Constantina Boikos, James A. Mansi
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1955 (2022)
This prospective cohort survey evaluated the concordance of clinicians’ perceptions of parental intentions and parents’ actual intentions to vaccinate their infants against influenza. During a routine healthy baby visit, clinicians provided paren
Externí odkaz:
https://doaj.org/article/e943a3275b2b4df380dd0809b4ddaf4e
Autor:
William A. Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield, Paul Roumeliotis, Emmanouil Rampakakis, Vivien Brown, John Yaremko, Paul Van Buynder, Constantina Boikos, James A. Mansi
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1957 (2022)
Adjuvanted trivalent influenza vaccine (aTIV) provides enhanced protection against seasonal influenza in children compared with nonadjuvanted trivalent influenza vaccine (TIV). This prospective cohort study assessed parental attitudes, beliefs, and i
Externí odkaz:
https://doaj.org/article/e0edc18f050c4904afc58419687a7893
Autor:
William A. Fisher, Vladimir Gilca, Michelle Murti, Alison Orth, Hartley Garfield, Paul Roumeliotis, Emmanouil Rampakakis, Vivien Brown, John Yaremko, Paul Van Buynder, Constantina Boikos, James A. Mansi
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1769 (2022)
The adjuvanted trivalent influenza vaccine (aTIV) provides enhanced protection against influenza for infants but is not publicly funded (NPF). The objective of this prospective cohort study of parents with children 6 through 23 months of age was to u
Externí odkaz:
https://doaj.org/article/aae2b71855fc401d9ea6d9ad04f76d15
Autor:
Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, John Schiller, Manale Ouakki, Elisabeth R. Unger
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 7-8, Pp 1980-1985 (2019)
The objective of this analysis was to compare the anti-HPV GMTs and their distribution after a 6-month or a 3–8 -y interval between two HPV vaccine doses. The results from two clinical trials, conducted by the same team in the same region, with ser
Externí odkaz:
https://doaj.org/article/c9f5139cb67d4e3bbb7ffac62647c981
Publikováno v:
BMC Geriatrics, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Older adults are at high risk for influenza-related complications including worsening frailty and function. We surveyed older Canadians to explore the impact of influenza and determine how influenza knowledge influences vaccinatio
Externí odkaz:
https://doaj.org/article/c8fc3b95d3de4c2c8f3f245c3a918640